United Kingdom· GB-APID-39327311000001104
Trixeo Aerosphere 5micrograms/dose / 7.2micrograms/dose / 160micrograms/dose pressurised inhaler
A medicinal product containing formoterol + glycopyrronium bromide + budesonide, registered in United Kingdom by AstraZeneca UK Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Formoterol + Glycopyrronium bromide + Budesonide
- Manufacturer
- AstraZeneca UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 3
- gtin05000456055765
- gtin5000456067966
- gtin5000456066624
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Formoterol + glycopyrronium bromide + budesonide in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaTRIXEO AEROSPHEREAstraZeneca AB, Södertälje
- FinlandRiltrava AerosphereAstraZeneca AB
- IrelandRiltrava Aerosphere 5/7.2/160 micrograms pressurised inhalation, suspensionAstraZeneca AB
- SwedenRiltrava Aerosphere 5 mikrogram/7,2 mikrogram/160 mikrogram Inhalationsspray, suspensionAstraZeneca AB
- United StatesBREZTRIAstraZeneca Pharmaceuticals LP
- NorwayTrixeo AerosphereAstraZeneca AB (2)
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Riltrava Aerosphere, Trixeo Aerosphere
- Liechtenstein · Riltrava Aerosphere, Trixeo Aerosphere
- Norway · Riltrava Aerosphere, Trixeo Aerosphere
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3ecfa241-b2a8-4020-8a01-a000e46b5641 GET /v1/drugs/3ecfa241-b2a8-4020-8a01-a000e46b5641?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "39327311000001104",
"desc": "Trixeo Aerosphere 5micrograms/dose / 7.2micrograms/dose / 160micrograms/dose pressurised inhaler (AstraZeneca UK Ltd)",
"form": "Pressurised inhalation",
"vpid": "39343511000001103",
"source": "dmd",
"vtm_id": "39335111000001107",
"strength": "7.2 microgram",
"substance": "Formoterol + Glycopyrronium bromide + Budesonide",
"ingredient": "Glycopyrronium bromide",
"supplier_code": "3583301000001102"
}See everything about formoterol + glycopyrronium bromide + budesonide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.